Product Name: Human CEACAM1 / CD66a Antibody (Chaim Sheba Med. Cntr. patent anti-CEACAM1, Research Use)
Catalog Number: NBR-0597
Target Name: CEACAM1 / CD66a
Trade Name: Chaim Sheba Med. Cntr. patent anti-CEACAM1
Antibody Drug Description: The drug is a recombinant fully human anti-CEACAM1 monoclonal antibody, being developed by Chaim Sheba Med. Cntr. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: CD66a
Synonyms: BGP; BGP1; CD66a
Target Description: CEACAM1 (CEA Cell Adhesion Molecule 1) is a Protein Coding gene. Diseases associated with CEACAM1 include Acute Gonococcal Endometritis and Adenomatoid Tumor. Among its related pathways are Innate Immune System and Cell surface interactions at the vascular wall. Gene Ontology (GO) annotations related to this gene include protein homodimerization activity. An important paralog of this gene is CEACAM5.
Ensembl: ENSG00000079385
Uniprot: P13688